000303656 001__ 303656
000303656 005__ 20250824022539.0
000303656 0247_ $$2doi$$a10.2196/71906
000303656 0247_ $$2pmid$$apmid:40824687
000303656 0247_ $$2ISSN$$a1439-4456
000303656 0247_ $$2ISSN$$a1438-8871
000303656 0247_ $$2altmetric$$aaltmetric:180395935
000303656 037__ $$aDKFZ-2025-01719
000303656 041__ $$aEnglish
000303656 082__ $$a610
000303656 1001_ $$00009-0005-8821-1471$$aManuilova, Iryna$$b0
000303656 245__ $$aUncovering the Understanding of the Concept of Patient Similarity in Cancer Research and Treatment: Scoping Review.
000303656 260__ $$aRichmond, Va.$$bHealthcare World$$c2025
000303656 3367_ $$2DRIVER$$aarticle
000303656 3367_ $$2DataCite$$aOutput Types/Journal article
000303656 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1755611488_6401$$xReview Article
000303656 3367_ $$2BibTeX$$aARTICLE
000303656 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000303656 3367_ $$00$$2EndNote$$aJournal Article
000303656 520__ $$aPatient similarity is a fundamental concept in precision oncology, offering a pathway to personalized medicine by identifying patterns and shared characteristics among patients. This concept enables stratification into clinically meaningful subgroups, prediction of treatment responses, and the tailoring of therapeutic interventions to individual needs. Despite its transformative potential, the definition, measurement, and clinical application of patient similarity remain inconsistently established, creating challenges in its integration into cancer research and clinical practice.This study aimed to synthesize evidence on the multidimensional concept of patient similarity in cancer research by analyzing its application across different points of possible data types, methodological frameworks, biological contexts, and commonly studied cancer types.This scoping review followed the PRISMA-ScR (Preferred Reporting Items for Systematic Reviews and Meta-Analyses Extension for Scoping Reviews) framework and the Joanna Briggs Institute guidelines. A systematic search was conducted across PubMed, MEDLINE, LIVIVO, and Web of Science (covering the period from 1998 to February 2024) and was supplemented by snowball sampling and manual searches. Duplicate records were removed, and study selection was carried out in 3 phases: title and abstract screening, disagreement resolution, and full-text screening. Each step was independently performed by 2 reviewers in Rayyan, with conflicts resolved by a third reviewer. Data extraction was performed using a predefined template to capture methodological approaches, data types, cancer types, and research objectives related to similarity in patients with cancer.This scoping review synthesized evidence from 137 studies, emphasizing the multidimensional concept of patient similarity in cancer research, which integrates diverse data types, methodological frameworks, research objectives, and cancer types. Transcriptomic data (92/137, 67.1%) and clinical data (65/137, 47.4%) were the most frequently used, often combined to enhance the comprehensiveness of similarity analyses. Machine learning (76/137, 55.5%) and network-based approaches (72/137, 52.5%) were prominent methods, reflecting their capacity to handle complex, high-dimensional data and uncover intricate relationships. Cancer subtype identification (70/137, 51.1%) and biomarker discovery (41/137, 29.9%) were the primary research objectives, underscoring the centrality of patient similarity in precision oncology. Breast, lung, and brain cancers were the most frequently studied, benefiting from established research frameworks and abundant datasets. Conversely, rare cancers were underrepresented, highlighting a critical gap in the generalizability of current methodologies.This comprehensive scoping review examines the concept of patient similarity in cancer research and highlights the critical role of a multilayered perspective in capturing its complexity and identification to enhance understanding and application in precision oncology.
000303656 536__ $$0G:(DE-HGF)POF4-312$$a312 - Funktionelle und strukturelle Genomforschung (POF4-312)$$cPOF4-312$$fPOF IV$$x0
000303656 588__ $$aDataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de
000303656 650_7 $$2Other$$acancer research
000303656 650_7 $$2Other$$acancer similarity metrics
000303656 650_7 $$2Other$$apatient similarity
000303656 650_7 $$2Other$$aprecision oncology
000303656 650_7 $$2Other$$ascoping review
000303656 7001_ $$00009-0001-7946-8559$$aBossenz, Jan$$b1
000303656 7001_ $$00009-0003-6925-5941$$aWeise, Annemarie Bianka$$b2
000303656 7001_ $$00009-0001-2887-7109$$aBoehm, Dominik$$b3
000303656 7001_ $$00000-0002-8024-2178$$aDöbel, Marvin$$b4
000303656 7001_ $$00000-0002-5153-0269$$aWerle, Silke D$$b5
000303656 7001_ $$00000-0002-1014-4521$$aUstjanzew, Arsenij$$b6
000303656 7001_ $$00000-0002-0491-3929$$aReimer, Niklas$$b7
000303656 7001_ $$00009-0007-3980-8233$$aStrantz, Cosima$$b8
000303656 7001_ $$00000-0002-1269-9360$$aUnberath, Philipp$$b9
000303656 7001_ $$0P:(DE-He78)374d2ab968929c8e96e9c227b676d7ab$$aMetzger, Patrick$$b10$$udkfz
000303656 7001_ $$00000-0002-8381-6624$$aPauli, Thomas$$b11
000303656 7001_ $$00000-0002-3856-7956$$aSchulze, Susann$$b12
000303656 7001_ $$00009-0004-2886-9485$$aHiemer, Sonja$$b13
000303656 7001_ $$00009-0000-9713-5806$$aOguztürk, Irmak$$b14
000303656 7001_ $$0P:(DE-He78)02340d3461eee53dd43e8f48feaf4633$$aKamkar, Leila$$b15$$udkfz
000303656 7001_ $$00000-0002-4759-5254$$aKestler, Hans A$$b16
000303656 7001_ $$aBusch, Hauke$$b17
000303656 7001_ $$0P:(DE-He78)fc949170377b58098e46141d95c72661$$aBrors, Benedikt$$b18$$udkfz
000303656 7001_ $$00000-0003-4369-3591$$aChristoph, Jan$$b19
000303656 773__ $$0PERI:(DE-600)2028830-X$$a10.2196/71906$$gVol. 27, p. e71906 -$$pe71906$$tJournal of medical internet research$$v27$$x1439-4456$$y2025
000303656 909CO $$ooai:inrepo02.dkfz.de:303656$$pVDB
000303656 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)374d2ab968929c8e96e9c227b676d7ab$$aDeutsches Krebsforschungszentrum$$b10$$kDKFZ
000303656 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)02340d3461eee53dd43e8f48feaf4633$$aDeutsches Krebsforschungszentrum$$b15$$kDKFZ
000303656 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)fc949170377b58098e46141d95c72661$$aDeutsches Krebsforschungszentrum$$b18$$kDKFZ
000303656 9131_ $$0G:(DE-HGF)POF4-312$$1G:(DE-HGF)POF4-310$$2G:(DE-HGF)POF4-300$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vFunktionelle und strukturelle Genomforschung$$x0
000303656 9141_ $$y2025
000303656 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bJ MED INTERNET RES : 2022$$d2024-12-06
000303656 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2024-12-06
000303656 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2024-12-06
000303656 915__ $$0StatID:(DE-HGF)0501$$2StatID$$aDBCoverage$$bDOAJ Seal$$d2023-04-12T14:53:43Z
000303656 915__ $$0StatID:(DE-HGF)0500$$2StatID$$aDBCoverage$$bDOAJ$$d2023-04-12T14:53:43Z
000303656 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bDOAJ : Peer review$$d2023-04-12T14:53:43Z
000303656 915__ $$0LIC:(DE-HGF)CCBYNV$$2V:(DE-HGF)$$aCreative Commons Attribution CC BY (No Version)$$bDOAJ$$d2023-04-12T14:53:43Z
000303656 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2024-12-06
000303656 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2024-12-06
000303656 915__ $$0StatID:(DE-HGF)1110$$2StatID$$aDBCoverage$$bCurrent Contents - Clinical Medicine$$d2024-12-06
000303656 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2024-12-06
000303656 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2024-12-06
000303656 915__ $$0StatID:(DE-HGF)0600$$2StatID$$aDBCoverage$$bEbsco Academic Search$$d2024-12-06
000303656 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bASC$$d2024-12-06
000303656 915__ $$0StatID:(DE-HGF)9905$$2StatID$$aIF >= 5$$bJ MED INTERNET RES : 2022$$d2024-12-06
000303656 915__ $$0StatID:(DE-HGF)0561$$2StatID$$aArticle Processing Charges$$d2024-12-06
000303656 915__ $$0StatID:(DE-HGF)0700$$2StatID$$aFees$$d2024-12-06
000303656 9201_ $$0I:(DE-He78)M130-20160331$$kM130$$lClinical Trial Office$$x0
000303656 9201_ $$0I:(DE-He78)B340-20160331$$kB340$$lTranslationale Medizinische Onkologie$$x1
000303656 9201_ $$0I:(DE-He78)B330-20160331$$kB330$$lAngewandte Bioinformatik$$x2
000303656 9201_ $$0I:(DE-He78)HD01-20160331$$kHD01$$lDKTK HD zentral$$x3
000303656 980__ $$ajournal
000303656 980__ $$aVDB
000303656 980__ $$aI:(DE-He78)M130-20160331
000303656 980__ $$aI:(DE-He78)B340-20160331
000303656 980__ $$aI:(DE-He78)B330-20160331
000303656 980__ $$aI:(DE-He78)HD01-20160331
000303656 980__ $$aUNRESTRICTED